Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Apple
AAPL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 417.39%15.69M | -811.01%-6.72M | 794.12%23.57M | 90.43%-618K | 73.84%-540K | 77.66%-4.94M | -90.08%945K | 120.09%2.64M | -351.19%-6.46M | 87.94%-2.06M |
Net profit before non-cash adjustment | 130.35%6.9M | 129.09%4.47M | 288.44%2.22M | 102.75%107K | 104.72%109K | -4.31%-22.74M | -39.13%-15.37M | 88.40%-1.18M | -229.75%-3.89M | -515.29%-2.31M |
Total adjustment of non-cash items | 132.97%23.4M | 2.75%7.91M | 898.15%13.46M | 2,746.15%1.11M | -3.56%922K | 46.71%10.04M | 399.42%7.7M | -66.59%1.35M | -95.08%39K | 100.84%956K |
-Depreciation and amortization | 657.26%19.65M | 1,212.79%7.29M | 1,356.86%11.15M | -17.79%661K | 18.68%559K | 47.53%2.6M | -23.66%555K | 123.03%765K | 100.50%804K | 63.54%471K |
-Reversal of impairment losses recognized in profit and loss | --0 | ---- | ---- | ---- | ---- | 109.67%7.05M | ---- | ---- | ---- | ---- |
-Disposal profit | 90.14%-129K | -2,152.27%-903K | 1,900.00%774K | --0 | --0 | -420.59%-1.31M | 101.53%44K | -101.29%-43K | -2,576.00%-1.34M | 270.59%29K |
-Other non-cash items | 126.52%3.88M | 2,584.21%1.53M | 145.37%1.54M | -21.64%449K | -20.39%363K | 29.80%1.71M | -82.41%57K | 79.89%626K | 29.64%573K | 122.44%456K |
Changes in working capital | -288.41%-14.61M | -321.84%-19.1M | 220.54%7.9M | 29.67%-1.84M | -120.96%-1.57M | 208.08%7.76M | -54.76%8.61M | 135.10%2.46M | -149.67%-2.61M | 96.08%-711K |
-Change in receivables | -13,200.00%-27.38M | -9,800.00%-6.53M | -173.60%-14.04M | 93.30%-1.6M | -202.97%-5.21M | 102.18%209K | -101.56%-66K | 222.29%19.07M | -68.00%-23.86M | 191.57%5.06M |
-Change in payables | -41.37%7.46M | -238.23%-20.66M | 216.80%24.65M | -105.22%-1.24M | 195.21%4.71M | 385.15%12.72M | 88.19%14.94M | -65.61%-21.1M | 83.79%23.82M | 60.81%-4.94M |
-Changes in other current assets | 202.79%5.31M | 229.07%8.09M | -160.36%-2.71M | 139.21%1.01M | -29.42%-1.07M | -175.22%-5.17M | -191.17%-6.27M | 2,392.35%4.49M | -1,411.73%-2.57M | ---826K |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -65.48%-4.31M | -178.58%-1.61M | -114.29%-1.65M | 15.37%-578K | 17.74%-473K | -43.72%-2.61M | -12.21%-579K | -69.23%-770K | -30.34%-683K | -80.25%-575K |
Interest received (cash flow from operating activities) | ||||||||||
Tax refund paid | -225.68%-2.77M | -925K | -1.75M | -293.55%-60K | 96.70%-29K | 44.25%-849K | 0 | 0 | 106.71%31K | -27.35%-880K |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating cash flow | 202.54%8.61M | -2,629.23%-9.26M | 980.81%20.17M | 82.34%-1.26M | 70.39%-1.04M | 67.02%-8.4M | -95.77%366K | 113.75%1.87M | -194.17%-7.11M | 80.58%-3.52M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -198.23%-15.52M | -2,107.12%-5.92M | -3,971.37%-9.53M | 95.15%-40K | 99.28%-32K | -20.83%-5.2M | 111.64%295K | 50.00%-234K | 36.81%-824K | ---4.44M |
Net business purchase and sale | ---55.71M | ---70.94M | --70.94M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net investment property transactions | --1.29M | --2.02M | ---- | ---- | ---16K | --0 | --0 | ---- | ---- | --0 |
Net investment product transactions | --0 | --0 | --0 | ---- | ---- | 7,662.07%4.39M | 213.79%66K | --724K | ---- | ---- |
Interest received (cash flow from investment activities) | -11.92%436K | -31.97%83K | -20.83%114K | 18.35%129K | -8.33%110K | 0.00%495K | -36.46%122K | 34.58%144K | 32.93%109K | 5.26%120K |
Investing cash flow | -21,416.10%-69.5M | -15,578.47%-74.76M | 9,490.22%60.8M | -2,029.89%-55.6M | 101.43%62K | 91.65%-323K | 120.12%483K | 275.62%634K | 335.76%2.88M | -3,890.35%-4.32M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 417.62%22.73M | 1,163.14%81.92M | -1,487.52%-57.36M | 85.46%-313K | -5.66%-1.51M | -143.53%-7.16M | -678.28%-7.71M | 160.33%4.13M | -127.33%-2.15M | -117.99%-1.43M |
Net common stock issuance | --0 | ---- | ---- | ---- | ---- | -67.15%11.7M | ---- | ---- | ---- | ---- |
Increase or decrease of lease financing | ---32K | ---80K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net other fund-raising expenses | -2,790.79%-25.43M | 50.53%-702K | -347.14%-3.03M | -1,297.69%-20.59M | -142.59%-1.11M | 126.76%945K | 36.76%-1.42M | 140.47%1.22M | -457.95%-1.47M | 270.45%2.61M |
Financing cash flow | -149.75%-2.73M | 3,049.57%81.13M | -1,226.11%-60.34M | -476.42%-20.9M | -322.35%-2.63M | -87.63%5.49M | 135.56%2.58M | 158.59%5.36M | -147.94%-3.63M | -97.19%1.18M |
Net cash flow | ||||||||||
Beginning cash position | -31.45%7.05M | -1,580.83%-53.68M | -1,655.56%-74.31M | -4.99%3.44M | -31.45%7.05M | 316.10%10.28M | -67.88%3.63M | -118.29%-4.23M | -81.15%3.63M | 316.10%10.28M |
Current changes in cash | -1,867.07%-63.62M | -184.23%-2.89M | 162.57%20.63M | -889.53%-77.76M | 45.85%-3.61M | -121.50%-3.23M | 441.82%3.43M | 166.23%7.86M | -300.25%-7.86M | -127.76%-6.66M |
End cash Position | -902.34%-56.57M | -902.34%-56.57M | -1,580.83%-53.68M | -1,655.56%-74.31M | -4.99%3.44M | -31.45%7.05M | -31.45%7.05M | -67.88%3.63M | -118.29%-4.23M | -81.15%3.63M |
Free cash flow | 49.16%-6.95M | -2,399.70%-15.2M | 550.55%10.62M | 83.67%-1.3M | 86.63%-1.07M | 54.06%-13.68M | -89.25%661K | 111.62%1.63M | -111.09%-7.94M | 55.66%-8.04M |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.